Drug discovery is slow, expensive and error-prone, and AI can only fix it with data biology doesn't yet have: clean, causal, and from the right human cells. CellCodex generates it. We build authentic human cells of the exact type a disease demands, recreate the disease in a dish, test it gene by gene, and read the response of every cell — training AI models that reveal what actually causes disease. We're proving it in Parkinson's, where the engine reaches therapeutic targets, and in drug-induced liver injury, where HepatoTox Oracle predicts which drugs will harm the liver. One programme discovers medicines; the other de-risks them. For more information visit: www.cellcodex.bio.
| Website | https://cellcodex.bio |
| Employees | 6 (3 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular CellCodex employee's phone or email?
Emmanouil Metzakopian is the CEO of CellCodex.
3 people are employed at CellCodex.